Relapse of imported Plasmodium vivax malaria is related to primaquine dose: A retrospective study

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Townell, Nicola ^a   Looke, David ^a,b   McDougall, David ^a   McCarthy, James S ^b,c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Australia; Epidemiology; Imported; Oceania; Plasmodium vivax; Primaquine; Relapse

Indexed keywords

PRIMAQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL EFFECTIVENESS; DRUG MEGADOSE; FEMALE; HUMAN; INFECTION PREVENTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PLASMODIUM VIVAX MALARIA; PRESCRIPTION; RELAPSE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THERAPY EFFECT;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PRIMAQUINE; QUEENSLAND; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862557759     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-214     Document Type: Article

References (27)

1. Queensland Notifiable Disease Report 1997-2001, Queensland Health Communicable Disease Unit 112 116
2. National Notifiable Diseases Surveillance Report 1-4, Australian Government Department of Helth and Ageing 2011
3. Notifications of imported malaria in Western Australia, 1990-2001: incidence, associated factors and chemoprophylaxis. Charles DM, Hart J, Davis WA, Sullivan E, Dowse GK, Davis TM, Med J Aust 2005 182 164 167 15720171 (Pubitemid 40298182)
4. Queensland Notifiable Disease Report 2002-2006, Queensland Health Communicable Disease Unit 184 187
5. High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S, Am J Trop Med Hyg 2008 78 736 740 18458306 (Pubitemid 351845129)
6. A rare glimpse at the efficacy of primaquine. Baird JK, Am J Trop Med Hyg 2007 76 201 202 17297025 (Pubitemid 351627763)
7. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ, Am J Trop Med Hyg 2006 75 402 415 16968913 (Pubitemid 46941297)
8. Can primaquine therapy for vivax malaria be improved? Baird JK, Rieckmann KH, Trends Parasitol 2003 19 115 120 10.1016/S1471-4922(03)00005-9 12643993 (Pubitemid 36338074)
9. Primaquine therapy for malaria. Baird JK, Hoffman SL, Clin Infect Dis 2004 39 1336 1345 10.1086/424663 15494911 (Pubitemid 39458520)
10. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Goller JL, Jolley D, Ringwald P, Biggs BA, Am J Trop Med Hyg 2007 76 203 207 17297026 (Pubitemid 351627764)
11. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Duarte EC, Pang LW, Ribeiro LC, Fontes CJ, Am J Trop Med Hyg 2001 65 471 476 11716100 (Pubitemid 33134579)
12. Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Bottieau E, Clerinx J, Van Den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A, Van Den Ende J, Am J Trop Med Hyg 2006 75 133 138 16837719 (Pubitemid 351627581)
13. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Galappaththy GN, Omari AA, Tharyan P, Cochrane Database Syst Rev 2007 24 1 D004389
14. UK malaria treatment guidelines. Lalloo DG, Delane S, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA, J Infect 2007 54 111 121 10.1016/j.jinf.2006.12.003 17215045 (Pubitemid 46083312)
15. Treatment of Malaria (Guidelines for Clinicians), Centre for Disease Control and Prevention 2011
16. Therapeutic Guidelines Antibiotics Therapeutic Guidelines 14 2010
17. Guidelines for the Treatment of Malaria. World Health Organisation 2 2010
18. Chloroquine resistance in Plasmodium vivax. Baird JK, Antimicrob Agents Chemother 2004 48 4075 4083 10.1128/AAC.48.11.4075-4083.2004 15504824 (Pubitemid 39434858)
19. Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers. Elliott JH, OBrien D, Leder K, Kitchener S, Schwartz E, Weld L, Brown GV, Kain KC, Torresi J, J Travel Med 2004 11 213 217 15541223
20. Malaria in US Marines returning from Somalia. Newton JA Jr, Schnepf GA, Wallace MR, Lobel HO, Kennedy CA, Oldfield EC 3rd, JAMA 1994 272 397 399 10.1001/jama.1994.03520050077034 8028173 (Pubitemid 24232179)
21. Imported malaria: prospective analysis of problems in diagnosis and management. Kain KC, Harrington MA, Tennyson S, Keystone JS, Clin Infect Dis 1998 27 142 149 10.1086/514616 9675468 (Pubitemid 28334433)
22. Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. Robinson P, Jenney AW, Tachado M, Yung A, Manitta J, Taylor K, Biggs BA, J Travel Med 2001 8 76 81 11285166 (Pubitemid 32479851)
23. New aspects of malaria imported from Ethiopia. Schwartz E, Sidi Y, Clin Infect Dis 1998 26 1089 1091 10.1086/520279 9597233 (Pubitemid 28215470)
24. Difficulties in the prevention, diagnosis, and treatment of imported malaria. Dorsey G, Gandhi M, Oyugi JH, Rosenthal PJ, Arch Intern Med 2000 160 2505 2510 10.1001/archinte.160.16.2505 10979063
25. Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers. Jelinek T, Nothdurft HD, Von Sonnenburg F, Loscher T, Am J Trop Med Hyg 1995 52 322 324 7741169
26. Relapse of imported vivax malaria despite standard-dose primaquine therapy: an investigation with molecular genotyping analyses. Chiang TY, Lin WC, Kuo MC, Ji DD, Fang CT, Clin Microbiol Infect 2012 Epub ahead of print. 10.1111/j.1469-0691.2012.03820.x
27. Resistance to therapies for infection by Plasmodium vivax. Baird JK, Clin Microbiol Rev 2009 22 508 534 10.1128/CMR.00008-09 19597012